Ratings by Bernstein SocGen Group (Aaron Gal)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/3/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2022 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/3/2022 | Viatris | VTRS | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/3/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2022 | Eli Lilly | LLY | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/3/2022 | Abbvie | ABBV | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/3/2022 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/3/2022 | Regeneron Pharma | REGN | Upgrade | Outperform (Market Perform) |
642.51 (968.83) |
50.79% | Details | |
| 12/15/2021 | Regeneron Pharma | REGN | Downgrade | Market Perform (Outperform) |
670.10 (834.04) |
24.47% | Details | |
| 11/2/2021 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/11/2021 | Biogen | BIIB | Upgrade | Outperform (Market Perform) |
406.94 (141.35) |
-65.27% | Details | |
| 5/5/2021 | Pfizer | PFE | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 4/1/2021 | Gilead Sciences | GILD | Upgrade | Outperform (Market Perform) |
65.50 (146.12) |
123.08% | Details | |
| 12/14/2020 | Viatris | VTRS | New Coverage | Market Perform (N/A) |
17.34 (16.32) |
-5.88% | Details | |
| 6/9/2020 | Biogen | BIIB | Downgrade | Market Perform (Outperform) |
306.72 (216.78) |
-29.32% | Details | |
| 5/1/2020 | Gilead Sciences | GILD | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/6/2020 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/6/2020 | Gilead Sciences | GILD | Downgrade | Market Perform (Outperform) |
67.40 (146.12) |
116.8% | Details | |
| 2/5/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/19/2018 | Biogen | BIIB | Downgrade | Market Perform (Outperform) |
330.15 (223.21) |
-32.39% | Details |
